| 1 Number of lesions that cleared after first cycle of treatment |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 2 Recurrence at 12 months |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 3 Number of lesions that cleared after second cycle of treatment |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 4 Number of participants with a good/excellent cosmetic outcome |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 5 Number of participants treated reporting pain |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 6 Number of adverse events > = 1 |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
